STAGE III HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8
Clinical trials for STAGE III HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Drug-Radiation combo aims to tame returning head and neck cancers
Disease control Not yet recruitingThis early-phase trial tests a new drug called camonsertib combined with precise, high-dose radiation for people whose head and neck cancer has come back or cannot be surgically removed. The drug blocks enzymes that help cancer cells grow, while the radiation targets tumors direc…
Matched conditions: STAGE III HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
Could a smaller dose of this cancer drug work just as well? a new trial aims to find out.
Disease control Not yet recruitingThis study is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control advanced cancers that have spread or cannot be removed by surgery. The goal is to see if this cheaper, simpler approach works as well as the standard dose, which co…
Matched conditions: STAGE III HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC